Compare BLKB & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLKB | BHVN |
|---|---|---|
| Founded | 1981 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2004 | 2022 |
| Metric | BLKB | BHVN |
|---|---|---|
| Price | $27.91 | $10.75 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $50.00 | $29.08 |
| AVG Volume (30 Days) | 624.5K | ★ 2.3M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.32 | 26.08 |
| EPS | ★ 0.67 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.26 | N/A |
| Revenue Next Year | $4.25 | N/A |
| P/E Ratio | $45.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.88 | $7.48 |
| 52 Week High | $74.86 | $18.57 |
| Indicator | BLKB | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 32.30 | 55.35 |
| Support Level | N/A | $8.25 |
| Resistance Level | $40.38 | $11.92 |
| Average True Range (ATR) | 1.61 | 0.85 |
| MACD | 0.06 | 0.17 |
| Stochastic Oscillator | 1.64 | 63.89 |
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.